Forecasting drug utilization and expenditure in a metropolitan health region
<p>Abstract</p> <p>Background</p> <p>New pharmacological therapies are challenging the healthcare systems, and there is an increasing need to assess their therapeutic value in relation to existing alternatives as well as their potential budget impact. Consequently, new...
Main Authors: | Korkmaz Seher, Kalin Mats, Wilking Nils, Persson Marie E, Wettermark Björn, Hjemdahl Paul, Godman Brian, Petzold Max, Gustafsson Lars L |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/10/128 |
Similar Items
-
The Early Awareness and Alert System in Sweden: History and Current Status
by: Irene Eriksson, et al.
Published: (2017-10-01) -
Forecasting military expenditure
by: Tobias Böhmelt, et al.
Published: (2014-05-01) -
Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.
by: Elisabetta Poluzzi, et al.
Published: (2015-01-01) -
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
by: Emanuel Raschi, et al.
Published: (2013-01-01) -
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
by: Alice Pisana, et al.
Published: (2022-06-01)